ID

34545

Description

Imaging Control Study, 3D Echo, MR and RHC.; ODM derived from: https://clinicaltrials.gov/show/NCT02198456

Link

https://clinicaltrials.gov/show/NCT02198456

Keywords

  1. 1/19/19 1/19/19 -
  2. 5/22/19 5/22/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 19, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Pulmonary Arterial Hypertension WHO Group I NCT02198456

Eligibility Pulmonary Arterial Hypertension WHO Group I NCT02198456

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age >17
Description

ID.1

Data type

boolean

pulmonary arterial hypertension who group i who are going to start a therapy with prostanoid
Description

ID.2

Data type

boolean

written informed consent
Description

ID.3

Data type

boolean

prostanoid naive
Description

ID.4

Data type

boolean

no change of the pulmonary arterial hypertension therapy within 3 weeks of inclusion into the study
Description

ID.5

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy and lactation period
Description

ID.6

Data type

boolean

women of childbearing potential who do not use an effective and secure method for birth control
Description

ID.7

Data type

boolean

severe chronic kidney insufficiency (glomerular filtration rate <30), which will remain for more than 3 months
Description

ID.8

Data type

boolean

liver insufficiency child c
Description

ID.9

Data type

boolean

life expectancy shorter than the course of the study (for example because of a malignant disease)
Description

ID.10

Data type

boolean

Similar models

Eligibility Pulmonary Arterial Hypertension WHO Group I NCT02198456

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age >17
boolean
ID.2
Item
pulmonary arterial hypertension who group i who are going to start a therapy with prostanoid
boolean
ID.3
Item
written informed consent
boolean
ID.4
Item
prostanoid naive
boolean
ID.5
Item
no change of the pulmonary arterial hypertension therapy within 3 weeks of inclusion into the study
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
pregnancy and lactation period
boolean
ID.7
Item
women of childbearing potential who do not use an effective and secure method for birth control
boolean
ID.8
Item
severe chronic kidney insufficiency (glomerular filtration rate <30), which will remain for more than 3 months
boolean
ID.9
Item
liver insufficiency child c
boolean
ID.10
Item
life expectancy shorter than the course of the study (for example because of a malignant disease)
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial